1-74489223-T-TA
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_015978.3(TNNI3K):c.2157dup(p.Glu720ArgfsTer8) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000545 in 1,612,326 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. L719L) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_015978.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TNNI3K | NM_015978.3 | c.2157dup | p.Glu720ArgfsTer8 | frameshift_variant | 22/25 | ENST00000326637.8 | |
FPGT-TNNI3K | NM_001112808.3 | c.2460dup | p.Glu821ArgfsTer8 | frameshift_variant | 24/27 | ||
LRRC53 | NM_001382280.1 | c.-26-5849_-26-5848insT | intron_variant | ENST00000294635.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TNNI3K | ENST00000326637.8 | c.2157dup | p.Glu720ArgfsTer8 | frameshift_variant | 22/25 | 1 | NM_015978.3 | P1 | |
LRRC53 | ENST00000294635.5 | c.-26-5849_-26-5848insT | intron_variant | 5 | NM_001382280.1 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000289 AC: 44AN: 152226Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000256 AC: 64AN: 249600Hom.: 0 AF XY: 0.000296 AC XY: 40AN XY: 134960
GnomAD4 exome AF: 0.000571 AC: 834AN: 1459982Hom.: 0 Cov.: 30 AF XY: 0.000565 AC XY: 410AN XY: 726268
GnomAD4 genome ? AF: 0.000289 AC: 44AN: 152344Hom.: 0 Cov.: 32 AF XY: 0.000268 AC XY: 20AN XY: 74490
ClinVar
Submissions by phenotype
See cases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Nov 18, 2019 | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: No criteria apply. - |
Atrial conduction disease Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Jan 11, 2024 | This sequence change creates a premature translational stop signal (p.Glu720Argfs*8) in the TNNI3K gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in TNNI3K cause disease. This variant is present in population databases (rs754423974, gnomAD 0.05%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with TNNI3K-related conditions. ClinVar contains an entry for this variant (Variation ID: 930852). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at